| Organism name | Ganoderma lucidum |
|---|---|
| Genus | Ganoderma |
| Family | Ganodermataceae |
| Kingdom | Fungi |
| Linked NCBI taxonomy name | Ganoderma lucidum |
|---|---|
| Linked NCBI taxonomy ID | 5315 |
| Linked level | species |
| Family in NCBI taxonomy | Ganodermataceae |
|---|---|
| ID | 5313 |
| Kingdom (Superkingdom) in NCBI taxonomy | Fungi |
|---|---|
| ID | 4751 |
| Plant class | |
|---|---|
| ID |
| Species | Activity |
|---|---|
| Ganoderma lucidum | Adaptogen |
| Ganoderma lucidum | Analgesic |
| Ganoderma lucidum | Antiaggregant |
| Ganoderma lucidum | Antiaging |
| Ganoderma lucidum | Antiallergic |
| Ganoderma lucidum | Antibacterial |
| Ganoderma lucidum | Anticonvulsant |
| Ganoderma lucidum | Antihistaminic |
| Ganoderma lucidum | Antiinflammatory |
| Ganoderma lucidum | Antioxidant |
| Ganoderma lucidum | Antitumor |
| Ganoderma lucidum | Antiviral |
| Ganoderma lucidum | Cytotoxic |
| Ganoderma lucidum | Expectorant |
| Ganoderma lucidum | Hepatoprotective |
| Ganoderma lucidum | Hypertensive |
| Ganoderma lucidum | Hypoglycemic |
| Ganoderma lucidum | Hypotensive |
| Ganoderma lucidum | Hypotriglyceridemic |
| Ganoderma lucidum | Immunostimulant |
| Ganoderma lucidum | Myorelaxant |
| Ganoderma lucidum | Radioprotective |
| Ganoderma lucidum | Sedative |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00031805
|
Ganoderic acid theta
/ (+)-Ganoderic acid theta. |
CHEMBL2205005
|
No. 55 |
|
||||
|
C00045318
|
Ganoderic acid AM1
|
CHEMBL2205003
|
No. 55 |
|
||||
|
C00045168
|
20-Hydroxyganoderic acid G
/ (+)-20-Hydroxyganoderic acid G |
No. 55 |
|
|||||
|
C00045153
|
12-Deacetylganoderic acid H
|
CHEMBL1922170
|
1 / 0 / 0 | No. 55 |
|
|||
|
C00044932
|
Methyl lucidenate Q
/ (+)-Methyl lucidenate Q |
CHEMBL460968
|
No. 55 |
|
||||
|
C00044931
|
Methyl lucidenate P
/ (+)-Methyl lucidenate P |
CHEMBL511952
|
No. 55 |
|
||||
|
C00044890
|
Lucidenic acid P
/ (+)-Lucidenic acid P |
CHEMBL469283
|
No. 55 |
|
||||
|
C00043677
|
Lucidenic acid N
/ (+)-Lucidenic acid N |
CHEMBL465487
|
2 / 1 / 0 | No. 55 |
|
|||
|
C00043530
|
Ganoderic acid beta
|
CHEMBL474065
|
No. 55 |
|
||||
|
C00040962
|
Ganoderic acid alpha
/ (-)-Ganoderic acid alpha |
No. 55 |
|
|||||
|
C00035104
|
Ganoderic acid V1
|
No. 55 |
|
|||||
|
C00023877
|
Lucidenic acid C
/ 11,15-Dioxo-3beta,7beta,12beta-trhydroxy-5alpha-lanost-8-en-24-oic acid |
CHEMBL465369
|
No. 55 |
|
||||
|
C00023878
|
Lucidenic acid F
/ 3,7,11,15-Tetraoxo-5alpha-lanost-8-en-24-oic acid |
No. 55 |
|
|||||
|
C00023879
|
Lucidenic acid G
/ 3,11-dioxo-4beta,7beta,15alpha-trihydroxy-5alpha-lanost-8-en-24-oic acid |
No. 55 |
|
|||||
|
C00023845
|
Ganoderic acid O
/ 20-Hydroxy-3,7,11,15,23-pentaoxo-5alpha-lanost-8-en-26-oic acid |
No. 55 |
|
|||||
|
C00023843
|
Ganoderic acid M
/ 7beta,12alpha-Dihydroxy-3,11,15,23-tetraoxo-5alpha-lanost-8-en-26-oic acid |
CHEMBL2203606
|
No. 55 |
|
||||
|
C00023870
|
Ganolucidic acid A
|
CHEMBL1087131
|
2 / 1 / 0 | No. 55 |
|
|||
|
C00023871
|
Ganolucidic acid B
|
CHEMBL1922176
|
1 / 0 / 0 | No. 55 |
|
|||
|
C00031804
|
Ganoderic acid eta
/ (+)-Ganoderic acid eta. |
No. 55 |
|
|||||
|
C00031803
|
Ganoderic acid epsilon
/ (+)-Ganoderic acid epsilon |
No. 55 |
|
|||||
|
C00023875
|
(+)-Lucidenic acid A
/ 3,11,15-Trioxo-7beta-hydroxy-5alpha-lanost-8-en-24-oic acid |
CHEMBL460969
|
2 / 1 / 0 | No. 55 |
|
|||
|
C00023876
|
(+)-Lucidenic acid B
/ 3,11,15-Trioxo-7beta,12beta-dihydroxy-5alpha-lanost-8-en-24-oic acid |
No. 55 |
|
|||||
|
C00030352
|
Ganoderenic acid G
/ (+)-Ganoderenic acid G |
No. 55 |
|
|||||
|
C00023831
|
Ganoderic acid L
/ 3beta,7beta,15alpha,20-Tetrahydroxy-11,23-dioxo-5alpha-lanost-8-en-26-oic acid |
No. 55 |
|
|||||
|
C00024054
|
Ganoderic acid G
|
CHEMBL1922175
|
1 / 0 / 0 | No. 55 |
|
|||
|
C00023885
|
Lucidenic acid M
/ 11-Oxo-3beta,7alpha,15alpha-trihydroxy-5alpha-lanost-8-en-24-oic acid |
No. 55 |
|
|||||
|
C00023884
|
Lucidenic acid L
/ 7,11,15-Trioxo-3beta,12beta-dihydroxy-5alpha-lanost-8-en-24-oic acid |
No. 55 |
|
|||||
|
C00023883
|
Lucidenic acid K
/ 3,7,11,15-Tetraoxo-12alpha-hydroxy-5alpha-lanost-8-en-24-oic acid |
No. 55 |
|
|||||
|
C00023882
|
Lucidenic acid J
/ 3,11,15-Trioxo-3beta,12beta-dihydroxy-5alpha-lanost-8-en-24-oic acid |
No. 55 |
|
|||||
|
C00023881
|
Lucidenic acid I
/ 7,11,15-Trioxo-3beta-hydroxy-5alpha-lanost-8-en-24-oic acid |
No. 55 |
|
|||||
|
C00023880
|
Lucidenic acid H
/ 11,15-dioxo-3beta,7beta-dihydroxy-5alpha-lanost-8-en-24-oic acid |
No. 55 |
|
|||||
|
C00023820
|
Ganoderic acid A
/ 7beta,15alpha-Dihydroxy-3,11,23-trioxo-5alpha-lanost-8-en-26-oic acid |
CHEMBL602899
|
3 / 2 / 2 | No. 55 |
|
|||
|
C00023821
|
Ganoderic acid B
|
CHEMBL1087180
|
3 / 1 / 0 | No. 55 |
|
|||
|
C00023822
|
Ganoderic acid C
/ Ganoderic acid C1 / 7beta-Hydroxy-3,11,15,23-tetraoxo-5alpha-lanost-8-en-26-oic acid |
CHEMBL1922180
CHEMBL2205002 |
1 / 0 / 0 | No. 55 |
|
|||
|
C00023823
|
Ganoderic acid D
/ 7beta,12alpha-Dihydroxy-3,11,23-tetraoxo-5alpha-lanost-8-en-26-oic acid |
CHEMBL1922180
CHEMBL2205002 |
1 / 0 / 0 | No. 55 |
|
|||
|
C00023824
|
Ganoderic acid E
/ 3,7,11,15,23-pentaoxo-5alpha-lanost-8-en-26-oic acid |
CHEMBL465514
|
2 / 1 / 0 | No. 55 |
|
|||
|
C00023825
|
Ganoderic acid F
/ 3,7,11,15,23-pentaoxo-12-acetoxy-5alpha-lanost-8-en-26-oic acid |
CHEMBL453981
|
No. 55 |
|
||||
|
C00023826
|
Ganoderic acid G
|
CHEMBL1922175
|
1 / 0 / 0 | No. 55 |
|
|||
|
C00023827
|
Ganoderic acid H
/ 3beta-Hydroxy-7,11,15,23-tetraoxo-12beta-acetoxy-5alpha-lanost-8-en-26-oic acid |
CHEMBL1922178
|
1 / 0 / 0 | No. 55 |
|
|||
|
C00023828
|
Ganoderic acid I
|
No. 55 |
|
|||||
|
C00023829
|
Ganoderic acid J
|
CHEMBL1922172
|
1 / 0 / 0 | No. 55 |
|
|||
|
C00023830
|
(+)-Ganoderic acid K
/ 3beta,15alpha-Dihydroxy-7,11,23-trioxo-5alpha-lanost-8-en-26-oic acid |
CHEMBL1922177
|
1 / 0 / 0 | No. 55 |
|
|||
|
C00030351
|
Ganoderenic acid D
|
CHEMBL1922179
|
1 / 0 / 0 | No. 55 |
|
|||
|
C00023849
|
Ganoderic acid U
|
No. 86 | No. 51 |
|
||||
|
C00023850
|
Ganoderic acid V
|
No. 86 | No. 51 |
|
||||
|
C00023854
|
Ganoderic acid Z
|
CHEMBL223317
|
No. 86 | No. 51 |
|
|||
|
C00045319
|
Ganoderic acid DM
|
CHEMBL1099224
|
1 / 3 / 4 | No. 91 |
|
|||
|
C00030693
|
Lucidumol B
|
CHEMBL1915762
|
2 / 1 / 0 | No. 91 |
|
|||
|
C00023874
|
Ganolucidic acid E
/ 15alpha-Hydroxy-3,11-dioxo-5alpha-lanosta-8,24E-dien-26-oic acid |
CHEMBL2203593
|
No. 91 |
|
||||
|
C00023873
|
(+)-Ganolucidic acid D
/ 15alpha,23-Dihydroxy-3,11-dioxo-5alpha-lanosta-8,24E-dien-26-oic acid |
No. 91 |
|
|||||
|
C00030692
|
Lucidumol A
/ (+)-Lucidumol A |
CHEMBL1917739
|
1 / 0 / 0 | No. 91 |
|
|||
|
C00033123
|
Lucialdehyde A
|
CHEMBL515080
|
No. 91 |
|
||||
|
C00023869
|
Ganodermatriol
|
C050247
|
No. 91 |
|
||||
|
C00023868
|
Ganodermadiol
/ 5alpha-Lanosta-7,9(11),24-triene-3beta,26-one |
CHEMBL240972
|
C050246
|
3 / 4 / 4 | No. 91 |
|
||
|
C00033124
|
Lucialdehyde B
/ (+)-Lucialdehyde B |
CHEMBL463372
|
No. 91 |
|
||||
|
C00023867
|
Ganodermanontriol
/ 24(S),25,26-Trihydroxy-5alpha-lanosta-7,9(11)-dien-3-one |
CHEMBL1915763
CHEMBL1921821 CHEMBL1923792 CHEMBL1923793 |
3 / 1 / 0 | No. 91 |
|
|||
|
C00033125
|
Lucialdehyde C
/ (+)-Lucialdehyde C |
No. 91 |
|
|||||
|
C00023862
|
Ganoderiol F
|
CHEMBL1915761
|
5 / 1 / 0 | No. 91 |
|
|||
|
C00023847
|
Ganoderic acid S
/ (22S,24E)-22-Acetoxy-3alpha-hydroxy-5alpha-lanosta-7,9(11),24-trien-26-oic acid |
CHEMBL1097154
|
No. 91 |
|
||||
|
C00023865
|
Ganoderiol I
|
No. 91 |
|
|||||
|
C00033850
|
Ganoderal A
/ (+)-Ganoderal A |
CHEMBL463972
|
No. 91 |
|
||||
|
C00033851
|
Ganoderal B
/ (+)-Ganoderal B |
No. 91 |
|
|||||
|
C00023864
|
(+)-Ganoderiol H
|
No. 91 |
|
|||||
|
C00023863
|
Ganoderiol G
|
No. 91 |
|
|||||
|
C00023853
|
Ganoderic acid Y
/ 3beta-Hydroxy-5alpha-lanosta-7,9(11),24-trien-26-oic acid |
CHEMBL1915760
|
2 / 1 / 0 | No. 91 |
|
|||
|
C00033852
|
Ganoderic aldehyde A
/ (+)-Ganoderic aldehyde A |
CHEMBL490377
|
No. 91 |
|
||||
|
C00023857
|
Ganoderiol A
/ (+)-Ganoderiol A / 5alpha-Lanosta-7,9(11)-diene-3beta,24,25,26-tetraol |
No. 91 |
|
|||||
|
C00023858
|
Ganoderiol B
/ 15alpha,26,27-Trihydroxy-5alpha-lanosta-7,9(11),24-trien-3-one |
No. 91 |
|
|||||
|
C00023859
|
Ganoderiol C
|
No. 91 |
|
|||||
|
C00023860
|
Ganoderiol D
|
No. 91 |
|
|||||
|
C00023861
|
Ganoderiol E
|
No. 91 |
|
|||||
|
C00023866
|
(+)-Ganodermanondiol
/ 24(S),25-Dihydroxy-5alpha-lanosta-7,9(11)-dien-3-one |
CHEMBL1098479
|
2 / 1 / 0 | No. 91 |
|
|||
|
C00023754
|
5,6-Dehydroergosterol
/ Ergosta-7,22-dien-3beta-ol / 24-Methylcholesta-7,22-dien-3beta-ol |
CHEMBL463973
CHEMBL560819 |
No. 111 | No. 11 |
|
|||
|
C00003652
|
Ergosterol
/ Ergosta-5,7,22-trien-3beta-ol |
CHEMBL222608
CHEMBL1232562 CHEMBL1512075 CHEMBL1741735 CHEMBL1965225 |
D004875
|
12 / 14 / 11 | No. 111 | No. 11 |
|
|
|
C00023765
|
Ergosta-7,22-dien-3-one
/ (24S)24-Methylcholesta-7,22-dien-3-one |
CHEMBL516711
CHEMBL1514671 |
C059439
|
1 / 0 / 1 | No. 111 | No. 11 |
|
|
|
C00003112
|
Cedrol
/ (+)-Cedrol / alpha-Cedrol |
CHEMBL1592444
CHEMBL1974890 |
C078669
|
5 / 14 / 11 | No. 161 | No. 38 |
|
|
|
C00007423
|
Pentadecanoic acid
/ n-Pentadecanoic acid |
CHEMBL460025
|
1 / 2 / 2 | No. 184 | No. 68 |
|
||
|
C00023836
|
(-)-Ganoderic acid Me
/ 3alpha,15alpha-Diacetoxy-5alpha-lanosta-7,9(11),24E-trien-26-oic acid |
No. 268 |
|
|||||
|
C00023841
|
Ganoderic acid Mj
/ 22-Acetoxy-3alpha-hydroxy-7alpha-methoxy-5alpha-lanosta-8,24E-dien-26-oic acid |
No. 268 |
|
|||||
|
C00023840
|
Ganoderic acid Mi
/ 3alpha-Acetoxy-7alpha-methoxy-5alpha-lanosta-8,24E-dien-26-oic acid |
No. 268 |
|
|||||
|
C00023839
|
Ganoderic acid Mh
/ 3alpha,22-Diacetoxy-7alpha,15alpha-dihydroxy-5alpha-lanosta-8,24E-dien-26-oic acid |
No. 268 |
|
|||||
|
C00023838
|
Ganoderic acid Mg
/ 3alpha,22-Diacetoxy-15alpha-hydroxy-7alpha-methoxy-5alpha-lanosta-8,24E-dien-26-oic acid |
No. 268 |
|
|||||
|
C00023837
|
(+)-Ganoderic acid Mf
/ 3alpha-Acetoxy-15alpha-hydroxy-5alpha-lanosta-7,9(11),24E-trien-26-oic acid |
No. 268 |
|
|||||
|
C00023842
|
Ganoderic acid Mk
/ 3alpha,22-Diacetoxy-15alpha-hydroxy-5alpha-lanosta-7,9(11),24E-dien-26-oic acid |
No. 268 |
|
|||||
|
C00023835
|
(-)-Ganoderic acid Md
/ 3alpha,22-Diacetoxy-7alpha-methoxy-5alpha-lanosta-8,24E-dien-26-oic acid |
No. 268 |
|
|||||
|
C00035103
|
Ganoderic acid Q
|
No. 268 |
|
|||||
|
C00023833
|
(-)-Ganoderic acid Mb
/ 3alpha,15alpha,22-Triacetoxy-7alpha-hydroxy-5alpha-lanosta-8,24E-dien-26-oic acid |
No. 268 |
|
|||||
|
C00023832
|
(-)-Ganoderic acid Ma
/ 3alpha,7alpha-Diacetoxy-15alpha-hydroxy-5alpha-lanosta-8,24E-dien-26-oic acid |
No. 268 |
|
|||||
|
C00023844
|
Ganoderic acid N
/ 7beta,20-Dihydroxy-3,11,15,23-tetraoxo-5alpha-lanost-8-en-26-oic acid |
CHEMBL2205004
|
2 / 0 / 0 | No. 268 |
|
|||
|
C00023846
|
Ganoderic acid R
/ (22S,24E)-3alpha,22-Diacetoxy-5alpha-lanosta-7,9(11),24-trien-26-oic acid |
No. 268 |
|
|||||
|
C00023848
|
Ganoderic acid T
/ (22S,24E)3alpha,15alpha,22-Triacetoxy-5alpha-lanosta-7,9(11),24-trien-26-oic acid |
CHEMBL2205006
|
No. 268 |
|
||||
|
C00035031
|
7-O-Methyl-ganoderic acid O
|
No. 268 |
|
|||||
|
C00035102
|
Ganoderic acid P
|
No. 268 |
|
|||||
|
C00023851
|
Ganoderic acid W
|
No. 268 |
|
|||||
|
C00023852
|
Ganoderic acid X
|
CHEMBL2205004
|
2 / 0 / 0 | No. 268 |
|
|||
|
C00023834
|
(-)-Ganoderic acid Mc
/ 3alpha,7alpha,22-Triacetoxy-15alpha-hydroxy-5alpha-lanosta-8,24E-dien-26-oic acid |
No. 268 |
|
|||||
|
C00012508
|
Cuparene
/ (+)-Cuparene / (R)-Cuparene / (R)-1-Methyl-4-(1,2,2-trimethylcyclopentyl)-benzene |
No. 309 |
|
|||||
|
C00003203
|
alpha-Ylangene
|
No. 333 | No. 38 |
|
||||
|
C00001224
|
Linoleic acid
/ (Z,Z)-9,12-Octadecadienoic acid |
CHEMBL267476
|
29 / 31 / 28 | No. 367 | No. 68 |
|
||
|
C00003131
|
beta-Farnesene
/ (E)-beta-Farnesene / beta-trans-Farnesene |
C062671
|
No. 404 | No. 38 |
|
|||
|
C00012602
|
Bazzanene
/ beta-Bazzanene / (+)-beta-Bazzanene / [R-(R*,S*)]-1,4-Dimethyl-4-(1-methyl-2-methylenecyclopentyl)cyclohexene |
No. 451 | No. 38 |
|
||||
|
C00034861
|
Isobazzanene
|
No. 451 | No. 38 |
|
||||
|
C00011617
|
AR-Curcumene
/ (R)-(-)-alpha-Curcumene |
CHEMBL469717
|
No. 456 | No. 38 |
|
|||
|
C00000805
|
alpha-Pinene
|
CHEMBL442565
|
C005451
|
3 / 3 / 2 | 0 / 1 | No. 476 | No. 35 |
|
|
C00000829
|
trans-Pinocarveol
|
No. 476 | No. 35 |
|
||||
|
C00007242
|
beta-Bisabolene
/ l-beta-Bisabolene / (-)-beta-Bisabolene |
CHEMBL444389
CHEMBL1077088 CHEMBL2001434 |
No. 701 | No. 38 |
|
|||
|
C00029339
|
E-Nerolidol
/ (E)-Nerolidol / trans-Nerolidol |
CHEMBL25424
CHEMBL508801 CHEMBL561014 CHEMBL1923157 |
3 / 3 / 1 | No. 726 | No. 38 |
|
||
|
C00007535
|
Phenylacetaldehyde
/ Benzeneacetaldehyde / Phenylacetic aldehyde |
C013192
|
3 / 0 | No. 885 |
|
|||
|
C00010301
|
Coriandrol
/ (S)-Linalool / S-(+)-Linalool / (+)-S-Linalool / (S)-3,7-Dimethyl-1,6-octadien-3-ol |
CHEMBL25306
CHEMBL235672 |
6 / 8 / 2 | No. 958 | No. 34 |
|
||
|
C00034888
|
-(-)-Linalool
/ (-)-R-Linalool |
CHEMBL25306
CHEMBL235672 |
6 / 8 / 2 | No. 958 | No. 34 |
|
||
|
C00029674
|
alpha-Terpineol
|
CHEMBL447597
CHEMBL449810 |
C016775
|
3 / 16 / 11 | No. 983 | No. 35 |
|
|
|
C00001228
|
Myristic acid
/ Tetradecanoic acid / n-Tetradecanoic acid |
CHEMBL111077
|
D019814
|
17 / 9 / 10 | 3 / 0 | No. 1141 | No. 68 |
|
|
C00030829
|
Pelargonic acid
/ n-Nonanoic acid |
CHEMBL108436
|
C008776
|
4 / 4 / 2 | 3 / 1 | No. 1141 | No. 68 |
|
|
C00001221
|
Lauric acid
/ Docosanoic acid / n-Dodecanoic acid |
CHEMBL108766
|
C030358
|
19 / 25 / 14 | 11 / 0 | No. 1141 | No. 68 |
|
|
C00001231
|
Caprylic acid
/ Octanoic acid / n-Octanoic acid |
CHEMBL324846
|
C031492
|
10 / 14 / 13 | 2 / 1 | No. 1141 | No. 68 |
|
|
C00033822
|
Ergosta-7,22-dien-3beta-yl palmitate
|
No. 1152 |
|
|||||
|
C00034795
|
alpha-Thujone
|
CHEMBL1444078
|
2 / 3 / 2 | No. 1161 | No. 35 |
|
||
|
C00023766
|
Cerevisterol
/ (-)-Cerevisteri / Ergosta-7,22-diene-5alpha,6beta,7beta-triol / (22E)-Ergosta-7,22-diene-3beta,5alpha,6beta-triol |
CHEMBL263108
CHEMBL491545 CHEMBL491546 |
C006954
|
No. 1193 |
|
|||
|
C00020282
|
Drimenol
/ delta7(8)-15-Hydroxyiresane |
No. 1202 | No. 38 |
|
||||
|
C00007636
|
delta-Cadinene
|
CHEMBL445759
|
No. 1524 | No. 39 |
|
|||
|
C00003035
|
Geranial
/ (E)-alpha-Citral |
CHEMBL1080997
|
6 / 7 / 9 | No. 1575 | No. 34 |
|
||
|
C00030758
|
2-Undecanone
/ Methyl nonyl ketone |
No. 1611 |
|
|||||
|
C00021903
|
alpha-trans-Bergamotene
/ trans-alpha-Bergamotene |
No. 1653 | No. 38 |
|
||||
|
C00000807
|
(R)-(-)-Carvone
|
CHEMBL15676
CHEMBL501949 |
8 / 9 / 9 | No. 1740 | No. 35 |
|
||
|
C00010891
|
(S)-(+)-Carvone
|
CHEMBL15676
CHEMBL501949 |
8 / 9 / 9 | No. 1740 | No. 35 |
|
||
|
C00034882
|
Nonane
/ n-Nonane |
CHEMBL335900
|
C017573
|
1 / 3 / 2 | 3 / 2 | No. 1749 |
|
|
|
C00030830
|
Nonanol
/ n-Nonanol |
CHEMBL24563
|
C014713
|
1 / 0 | No. 1749 |
|
||
|
C00030804
|
n-Decanal
|
C021170
|
2 / 0 | No. 1993 |
|
|||
|
C00032442
|
Undecanal
|
No. 1993 |
|
|||||
|
C00030828
|
Nonanal
/ n-Nonanal |
C008664
|
1 / 1 | No. 1993 |
|
|||
|
C00029330
|
(E)-2-Decenal
|
CHEMBL507518
|
No. 2140 |
|
||||
|
C00010974
|
o-Cymol
/ 0-Isopropyltoluene / 1-Isopropyl-2-methylbenzene |
C046257
|
No. 2172 | No. 35 |
|
|||
|
C00029341
|
(E,E)-2,4-Decadienal
/ 2-trans,4-trans-Decadienal |
CHEMBL443949
|
8 / 12 / 42 | No. 2201 |
|
|||
|
C00010927
|
Terpinene-4-ol
/ (-)-Terpinene-4-ol / (R)-(-)-p-Menth-1-en-4-ol |
CHEMBL507795
|
1 / 3 / 0 | No. 2215 |
|
|||
|
C00030200
|
Ergosterol peroxide
/ Ergosterol 5,8-peroxide / (-)-Ergosterol 5,8-peroxide / 5alpha,8alpha-Epidioxyergosta-6,22-dien-3beta-ol / (-)-5alpha,8alpha-Epidioxyergosta-6,22-dien-3beta-ol |
CHEMBL434750
CHEMBL515808 CHEMBL1801968 CHEMBL1969254 |
C036071
|
1 / 0 / 0 | 1 / 4 | No. 2300 |
|
|
|
C00034801
|
beta-Irone
|
No. 2480 | No. 38 |
|
||||
|
C00029334
|
(E)-Anethol
/ trans-Anethol / trans-1-(4-Methoxyphenyl)-1-propene |
CHEMBL452630
CHEMBL1468832 |
6 / 21 / 49 | No. 2748 | No. 6 |
|
||
|
C00034802
|
Bisabolol oxide B
|
No. 2789 |
|
|||||
|
C00029316
|
(2E)-Octenal
/ (E)-2-Octenal / trans-Oct-2-en-1-al |
CHEMBL448058
|
No. 2883 |
|
||||
|
C00034763
|
2-Amylfuran
/ 2-Pentylfuran |
No. 3145 |
|
|||||
|
C00023886
|
Lucidone A
|
CHEMBL2203600
|
No. 3165 |
|
||||
|
C00023888
|
Lucidone C
/ 3beta,7beta,15alpha-Trihydroxy-4,4,14alpha-trimethyl-11,20-dioxo-5alpha-pregn-8-ene |
No. 3165 |
|
|||||
|
C00023887
|
Lucidone B
/ 7beta-Hydroxy-4,4,14alpha-trimethyl-3,11,15,20-tetraoxo-5alpha-pregn-8-ene |
No. 3165 |
|
|||||
|
C00034880
|
n-Heptanal
|
CHEMBL18104
|
C046204
|
2 / 3 / 2 | 1 / 0 | No. 3593 |
|
|
|
C00001218
|
Caproic acid
/ Hexanoic acid / 1-Hexanoic acid / n-Hexanoic acid |
CHEMBL14184
|
C037652
|
5 / 0 / 0 | No. 3692 | No. 68 |
|
|
|
C00021380
|
Daucene
|
No. 4056 | No. 38 |
|
||||
|
C00034775
|
6-Methyl-5-hepten-2-one
|
CHEMBL46340
|
C029750
|
No. 5297 |
|
|||
|
C00000136
|
1,8-Cineole
|
CHEMBL485259
CHEMBL1397305 |
99 / 57 / 50 | No. 5413 | No. 35 |
|
||
|
C00034794
|
alpha-Pinene epoxide
|
CHEMBL274511
|
C053997
|
No. 7690 | No. 35 |
|
||
|
C00045197
|
8beta,9alpha-Dihydroganoderic acid J
/ (+)-8beta,9alpha-Dihydroganoderic acid J |
No. 8256 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P15121 | Aldose reductase | Enzyme | C00001218 C00023820 C00023821 C00023822 C00023823 C00023826 C00023827 C00023829 C00023830 C00023871 C00024054 C00030351 C00045153 | 0 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00000136 C00023821 C00023824 C00023853 C00023862 C00023866 C00023867 C00023868 C00023870 C00023875 C00030693 C00043677 | 1 / 0 |
| P06276 | Cholinesterase | Hydrolase | C00023821 C00023824 C00023853 C00023862 C00023866 C00023867 C00023868 C00023870 C00023875 C00030693 C00043677 | 0 / 0 |
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00000136 C00000805 C00001221 C00001224 C00001231 C00029334 C00029341 C00034795 C00034880 C00034882 | 3 / 2 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00000807 C00001221 C00001224 C00001231 C00003035 C00003112 C00003652 C00010891 C00029334 C00029341 | 0 / 0 |
| P10828 | Thyroid hormone receptor beta | NR1A2 | C00000807 C00001221 C00003035 C00003112 C00010301 C00010891 C00029339 C00030829 C00034888 | 3 / 1 |
| Q96RI1 | Bile acid receptor | NR1H4 | C00001221 C00001224 C00001228 C00023862 C00023867 C00030200 C00030692 | 0 / 0 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000136 C00001221 C00001228 C00010301 C00034795 C00034888 | 0 / 0 |
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00001224 C00003112 C00003652 C00010301 C00029339 C00034888 | 0 / 0 |
| P02545 | Prelamin-A/C | Unclassified protein | C00000136 C00001224 C00001231 C00003112 C00029334 C00029674 | 11 / 10 |
| P10275 | Androgen receptor | NR3C4 | C00000136 C00001221 C00001224 C00003035 C00023868 C00045319 | 3 / 4 |
| P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00000805 C00000807 C00001221 C00010891 C00029341 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00000136 C00001224 C00001228 C00001231 C00030829 | 0 / 0 |
| P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00001221 C00010301 C00010927 C00029674 C00034888 | 3 / 0 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000136 C00001224 C00003652 C00023765 C00029334 | 0 / 1 |
| Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00000807 C00001228 C00010891 C00030829 | 1 / 1 |
| P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00003652 C00010301 C00029674 C00034888 | 5 / 1 |
| Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00001218 C00001221 C00001228 C00001231 | 0 / 0 |
| Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00001218 C00001221 C00001228 C00001231 | 0 / 0 |
| Q9UGP5 | DNA polymerase lambda | Enzyme | C00001218 C00001221 C00001224 | 0 / 0 |
| P11387 | DNA topoisomerase 1 | Isomerase | C00023844 C00023852 C00023862 | 0 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000807 C00010891 C00029341 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00000136 C00001221 C00001224 | 1 / 1 |
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00023844 C00023852 C00023862 | 0 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00001224 C00003652 C00029339 | 0 / 0 |
| P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00001224 C00001228 C00007423 | 2 / 2 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00001218 C00001221 C00001224 | 0 / 0 |
| P11473 | Vitamin D3 receptor | NR1I1 | C00001228 C00003652 C00029341 | 2 / 3 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00000136 C00000805 C00003112 | 0 / 0 |
| P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00001221 C00001224 | 5 / 3 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00001224 C00001228 | 1 / 1 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00000807 C00010891 | 2 / 0 |
| P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00001221 C00001224 | 0 / 0 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000136 C00003652 | 0 / 0 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000136 C00001221 | 0 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00000136 C00001231 | 0 / 1 |
| Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00001224 C00001228 | 0 / 0 |
| O00255 | Menin | Unclassified protein | C00000807 C00010891 | 2 / 5 |
| Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00010301 C00034888 | 0 / 0 |
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00001221 C00001228 | 0 / 0 |
| O00519 | Fatty-acid amide hydrolase 1 | Enzyme | C00003035 C00034880 | 0 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000136 C00003652 | 0 / 1 |
| P10145 | Interleukin-8 | Secreted protein | C00001221 C00029341 | 0 / 0 |
| Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00001224 C00029341 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00000136 C00003652 | 4 / 3 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000136 C00003652 | 1 / 1 |
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00029334 C00029341 | 7 / 37 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000136 C00001224 | 0 / 0 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000807 C00010891 | 1 / 2 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001224 C00001228 | 0 / 0 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000136 C00003652 | 1 / 0 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00000136 | 0 / 0 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000136 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000136 | 1 / 1 |
| O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001228 | 0 / 0 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000136 | 0 / 0 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000136 | 1 / 0 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000136 | 0 / 0 |
| P28845 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | Enzyme | C00023820 | 1 / 1 |
| P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00001228 | 2 / 2 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000136 | 0 / 0 |
| P39748 | Flap endonuclease 1 | Enzyme | C00001228 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00000136 | 0 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000136 | 0 / 0 |
| Q8TCC7 | Solute carrier family 22 member 8 | Antiporter | C00001231 | 0 / 0 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000136 | 0 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00000136 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00000136 | 0 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00000136 | 1 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00000136 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00000136 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000136 | 0 / 0 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00000136 | 2 / 0 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00000136 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000136 | 0 / 0 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000136 | 1 / 8 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000136 | 1 / 0 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000136 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00000136 | 0 / 0 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000136 | 1 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000136 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00000136 | 0 / 0 |
| P03956 | Interstitial collagenase | M10A | C00000136 | 0 / 1 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000136 | 0 / 0 |
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00001221 | 7 / 3 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000136 | 0 / 0 |
| Q4U2R8 | Solute carrier family 22 member 6 | Antiporter | C00001231 | 0 / 0 |
| P51452 | Dual specificity protein phosphatase 3 | Ser_Thr_Tyr | C00001224 | 0 / 0 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000136 | 2 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000136 | 0 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000136 | 0 / 0 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000136 | 0 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000136 | 2 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000136 | 1 / 0 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000136 | 5 / 9 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000136 | 1 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00000136 | 0 / 0 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00000136 | 0 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000136 | 0 / 0 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000136 | 3 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000136 | 0 / 0 |
| P13726 | Tissue factor | Membrane receptor | C00001224 | 0 / 0 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00000136 | 0 / 0 |
| Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00000136 | 0 / 0 |
| P35236 | Tyrosine-protein phosphatase non-receptor type 7 | Tyr | C00001224 | 0 / 0 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000136 | 1 / 0 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000136 | 1 / 1 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000136 | 2 / 1 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 1 |
| P55055 | Oxysterols receptor LXR-beta | NR1H3 | C00000136 | 0 / 0 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00001224 | 3 / 3 |
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00001224 | 2 / 2 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00000136 | 1 / 2 |
| P05413 | Fatty acid-binding protein, heart | Other cytosolic protein | C00001224 | 0 / 0 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00030829 | 0 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00000136 | 2 / 2 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00000136 | 0 / 0 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000136 | 1 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00000136 | 0 / 0 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000136 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000136 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00000136 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000136 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00000136 | 0 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00000136 | 0 / 0 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000136 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00000136 | 0 / 0 |
| Q05193 | Dynamin-1 | Structural | C00001228 | 0 / 0 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000136 | 0 / 0 |
| P15090 | Fatty acid-binding protein, adipocyte | Other cytosolic protein | C00001224 | 0 / 0 |
| O14842 | Free fatty acid receptor 1 | Free fatty acid receptor | C00001224 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000136 | 0 / 0 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00000136 | 0 / 0 |
| P08246 | Neutrophil elastase | S1A | C00000136 | 2 / 1 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000136 | 2 / 2 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000136 | 1 / 1 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00000136 | 0 / 0 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000136 | 0 / 3 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000136 | 1 / 1 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00000136 | 0 / 1 |
| P31939 | Bifunctional purine biosynthesis protein PURH | Enzyme | C00003652 | 1 / 1 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000136 | 0 / 0 |
| P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00023820 | 1 / 1 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000136 | 0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00029334 | 0 / 0 |
| P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000136 | 0 / 0 |
| Q7Z2W7 | Transient receptor potential cation channel subfamily M member 8 | Unclassified protein | C00000136 | 0 / 0 |
| O60603 | Toll-like receptor 2 | Membrane receptor | C00001228 | 1 / 1 |
| P35610 | Sterol O-acyltransferase 1 | Enzyme | C00001224 | 0 / 0 |
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00003035 | 0 / 1 |
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00003035 | 1 / 4 |
| Q9NSA0 | Solute carrier family 22 member 11 | Transporter | C00001231 | 0 / 0 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000136 | 0 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00001221
C00001228
C00001231
C00030829
|
| 231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00030804
C00030828
C00034880
|
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00001221
C00007535
C00034882
|
| 128 | ADH5, ADH-3, ADHX, FALDH, FDH, GSH-FDH, GSNOR | alcohol dehydrogenase 5 (class III), chi polypeptide (EC:1.1.1.1 1.1.1.284) |
C00001221
C00001231
C00030829
|
| 199974 | CYP4Z1, CYP4A20 | cytochrome P450, family 4, subfamily Z, polypeptide 1 (EC:1.14.14.1) |
C00001221
C00001228
|
| 10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00001221
C00001228
|
| 217 | ALDH2, ALDH-E2, ALDHI, ALDM | aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3) |
C00030804
|
| 9970 | NR1I3, CAR, CAR1, MB67 | nuclear receptor subfamily 1, group I, member 3 |
C00030830
|
| 3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00034882
|
| 5241 | PGR, NR3C3, PR | progesterone receptor |
C00034882
|
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00007535
|
| 1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00001221
|
| 1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00001221
|
| 1579 | CYP4A11, CP4Y, CYP4A2, CYP4AII | cytochrome P450, family 4, subfamily A, polypeptide 11 (EC:1.14.15.3) |
C00001221
|
| 1646 | AKR1C2, AKR1C-pseudo, BABP, DD, DD2, DDH2, HAKRD, HBAB, MCDR2, SRXY8 | aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) |
C00007535
|
| 64127 | NOD2, ACUG, BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, NOD2B, PSORAS1 | nucleotide-binding oligomerization domain containing 2 |
C00001221
|
| 942 | CD86, B7-2, B7.2, B70, CD28LG2, LAB72 | CD86 molecule |
C00030829
|
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00001221
|
| 54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00001221
|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00030200
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
| #202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
| #608688 | Aicar transformylase/imp cyclohydrolase deficiency |
P31939
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 |
| #612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #300068 | Androgen insensitivity syndrome; ais |
P10275
|
| #312300 | Androgen insensitivity, partial; pais |
P10275
|
| #218030 | Apparent mineralocorticoid excess; ame |
P80365
|
| #613546 | Aromatase deficiency |
P11511
|
| #139300 | Aromatase excess syndrome; aexs |
P11511
|
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
| #601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| %606641 | Body mass index; bmi |
P37231
|
| #300615 | Brunner syndrome |
P21397
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #609338 | Carotid intimal medial thickness 1 |
P37231
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #604931 | Cortisone reductase deficiency 1; cortrd1 |
P28845
|
| #218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
| #606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
| #162800 | Cyclic neutropenia |
P08246
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #119900 | Digital clubbing, isolated congenital |
P15428
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #133239 | Esophageal cancer |
P04637
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #143500 | Gilbert syndrome |
P22309
P22310 |
| #137800 | Glioma susceptibility 1; glm1 |
P04626
P37231 |
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #603373 | Hyperthyroidism, familial gestational |
P16473
|
| #609152 | Hyperthyroidism, nonautoimmune |
P16473
|
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #246300 | Leprosy, susceptibility to, 3; lprs3 |
O60603
|
| #151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 P04637 |
| #608516 | Major depressive disorder; mdd |
P08172
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #174800 | Mccune-albright syndrome; mas |
P63092
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
| #159900 | Myoclonic dystonia |
P14416
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #257200 | Niemann-pick disease, type a |
P17405
|
| #607616 | Niemann-pick disease, type b |
P17405
|
| #601665 | Obesity |
P32245
P37231 |
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #166350 | Osseous heteroplasia, progressive; poh |
P63092
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
|
| #260500 | Papilloma of choroid plexus; cpp |
P04637
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #172700 | Pick disease of brain |
P10636
|
| #102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
| #601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
| #103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
| #603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
| #612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
| #274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
| #145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #112100 | Yt blood group antigen |
P22303
|
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00344 | Leprosy |
O60603
(related)
|
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
| H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
| H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
| H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
| H00006 | Hairy-cell leukemia |
P04637
(related)
|
| H00008 | Burkitt lymphoma |
P04637
(related)
|
| H00009 | Adult T-cell leukemia |
P04637
(related)
|
| H00010 | Multiple myeloma |
P04637
(related)
|
| H00013 | Small cell lung cancer |
P04637
(related)
|
| H00014 | Non-small cell lung cancer |
P04637
(related)
|
| H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
| H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
| H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
| H00029 | Vulvar cancer |
P04637
(related)
|
| H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
| H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
| H00038 | Malignant melanoma |
P04637
(related)
|
| H00039 | Basal cell carcinoma |
P04637
(related)
|
| H00040 | Squamous cell carcinoma |
P04637
(related)
|
| H00041 | Kaposi's sarcoma |
P04637
(related)
|
| H00044 | Cancer of the anal canal |
P04637
(related)
|
| H00047 | Gallbladder cancer |
P04637
(related)
|
| H00048 | Hepatocellular carcinoma |
P04637
(related)
|
| H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
| H01007 | Choroid plexus papilloma |
P04637
(related)
|
| H00021 | Renal cell carcinoma |
P04637
(marker)
|
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00024 | Prostate cancer |
P10275
(related)
|
| H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
| H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
| H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
| H00342 | Tuberculosis |
P11473
(related)
|
| H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
| H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
| H00794 | Aromatase excess syndrome |
P11511
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
| H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
| H01269 | Congenital hyperthyroidism |
P16473
(related)
|
| H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
| H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H00208 | Hyperbilirubinemia |
P22309
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H01111 | Cortisone reductase deficiency (CRD) |
P28845
(related)
|
| H00966 | AICA-ribosiduria |
P31939
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00409 | Type II diabetes mellitus |
P37231
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
| H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
| H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
| H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
| H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
| H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
| H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D003877 | Dermatitis, Contact |
C00000805
|
| D009336 | Necrosis |
C00030828
|
| D011041 | Poisoning |
C00030829
|
| D017453 | Dermatitis, Irritant |
C00034882
|
| D004890 | Erythema |
C00034882
|
| D003128 | COMA |
C00001231
|
| D001424 | Bacterial Infections |
C00030200
|
| D009369 | Neoplasms |
C00030200
|
| D011471 | Prostatic Neoplasms |
C00030200
|
| D014777 | Virus Diseases |
C00030200
|